The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001754.5(RUNX1):c.613+14C>G

CA2573157345

1597566 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 42b26001-7bd7-4d32-8c95-f95452af2662
Approved on: 2024-06-24
Published on: 2024-06-24

HGVS expressions

NM_001754.5:c.613+14C>G
NM_001754.5(RUNX1):c.613+14C>G
NC_000021.9:g.34859460G>C
CM000683.2:g.34859460G>C
NC_000021.8:g.36231757G>C
CM000683.1:g.36231757G>C
NC_000021.7:g.35153627G>C
NG_011402.2:g.1130252C>G
ENST00000675419.1:c.613+14C>G
ENST00000300305.7:c.613+14C>G
ENST00000344691.8:c.532+14C>G
ENST00000358356.9:c.532+14C>G
ENST00000399237.6:c.577+14C>G
ENST00000399240.5:c.532+14C>G
ENST00000437180.5:c.613+14C>G
ENST00000467577.1:n.105+14C>G
ENST00000482318.5:c.*203+14C>G
NM_001001890.2:c.532+14C>G
NM_001122607.1:c.532+14C>G
NM_001754.4:c.613+14C>G
NM_001001890.3:c.532+14C>G
NM_001122607.2:c.532+14C>G
More

Likely Benign

Met criteria codes 3
PM2_Supporting BP7 BP4
Not Met criteria codes 23
PVS1 PS1 PS2 PS4 PS3 BA1 PP4 PP1 PP3 PP2 PM6 PM5 PM3 PM1 PM4 BS4 BS3 BS1 BS2 BP5 BP2 BP3 BP1

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.613+14C>G is an intronic variant. This variant is absent from gnomAD v2.1.1 (mean depth of coverage > 60) and from gnomAD v3.1.1 (mean depth of coverage 30) (PM2_Supporting). It is not predicted by SpliceAI to impact splicing (≤0.20). In addition, it occurs at a nucleotide that is not conserved as shown by phyloP100 (0.09) (BP4, BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (mean depth of coverage > 60 for exome and genome combined) and from gnomAD v3.1.1 (mean depth of coverage 30).
BP7
The c.613+14C>G (p.?) variant (NM_001754.5) is a synonymous variant that is not predicted by SpliceAI to impact splicing (≤0.20). In addition, it occurs at a nucleotide that is not conserved as shown by phyloP100 (0.09) (BP4, BP7).
BP4
This is an intronic variant therefore no REVEL score is applicable and SpliceAI score is ≤0.20 (0) (BP4).
Not Met criteria codes
PVS1
This variant is not a null variant.
PS1
This is an intronic variant.
PS2
To our knowledge, no publication has reported this variant as de novo to date.
PS4
To our knowledge, no publication has reported this variant to date. Clinvar has an entry for this variant but the affected status is unknown.
PS3
To our knowledge, this synonymous variant was not evaluated in transactivation assays.

BA1
This variant is absent from gnomAD v2.1.1 (mean depth of coverage > 60 for exome and genome combined) and from gnomAD v3.1.1 (mean depth of coverage 30).
PP4
This rule is not applicable to the MMVCEP
PP1
To our knowledge, no publication has reported this variant to date. Clinvar has an entry for this variant but the affected status is unknown.
PP3
This is an intronic variant therefore no REVEL score is applicable and SpliceAI score is <0.38 (0) (PP3).
PP2
This rule is not applicable to the MMVCEP.
PM6
To our knowledge, no publication has reported this variant as de novo to date.
PM5
This is an intronic variant.
PM3
This rule is not applicable to the MMVCEP
PM1
This is an intronic variant.
PM4
This is not an in-frame deletion/insertion.
BS4
To our knowledge, no publication has reported this variant to date. Clinvar has an entry for this variant but the affected status is unknown.
BS3
To our knowledge, this synonymous variant was not evaluated in transactivation assays.

BS1
This variant is absent from gnomAD v2.1.1 (mean depth of coverage > 60 for exome and genome combined) and from gnomAD v3.1.1 (mean depth of coverage 30).
BS2
This rule is not applicable to the MMVCEP.
BP5
This rule is not applicable to the MMVCEP
BP2
To our knowledge, no publication has reported this information to date.
BP3
This rule is not applicable to the MMVCEP
BP1
This rule is not applicable to the MMVCEP.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.